ReviewDiabetes & metabolism journal2025

SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application.

Jae Hyun BaePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.